当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析 - 现金流量表

东诚药业

(002675)

  

流通市值:94.71亿  总市值:105.05亿
流通股本:7.43亿   总股本:8.25亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,973,825,487.911,215,796,362.16608,119,198.82,767,898,800.96
  收到的税费返还21,209,821.665,910,623.783,516,592.1265,836,787.69
  收到其他与经营活动有关的现金55,321,695.7641,314,468.9117,050,594.3745,418,554.71
  经营活动现金流入小计2,050,357,005.331,263,021,454.85628,686,385.292,879,154,143.36
  购买商品、接受劳务支付的现金789,079,437.71503,481,160.8279,638,296.38994,764,300.59
  支付给职工以及为职工支付的现金431,921,127.34307,542,225.41182,675,820.95515,676,516.61
  支付的各项税费211,441,220.34139,644,689.4164,952,979.81266,899,287.61
  支付其他与经营活动有关的现金361,518,095.75250,068,015.5132,817,819.68521,963,644.09
  经营活动现金流出小计1,793,959,881.141,200,736,091.12660,084,916.822,299,303,748.9
  经营活动产生的现金流量净额256,397,124.1962,285,363.73-31,398,531.53579,850,394.46
二、投资活动产生的现金流量:
  收回投资收到的现金628,500,000443,500,000260,500,0001,144,840,000
  取得投资收益收到的现金4,173,750.773,102,214.041,024,660.624,760,198.07
  处置固定资产、无形资产和其他长期资产收回的现金净额68,306.8353,686.1950541,740.86
  处置子公司及其他营业单位收到的现金净额11,558,000---115.49
  收到的其他与投资活动有关的现金806,700806,600818,333.751,320,000
  投资活动现金流入小计645,106,757.6447,462,500.23262,343,044.371,151,461,823.44
  购建固定资产、无形资产和其他长期资产支付的现金229,686,677.12180,665,348.0674,296,959.11360,817,831.77
  投资支付的现金1,025,257,695.78878,157,462.78208,000,0001,345,023,879.45
  支付其他与投资活动有关的现金105,700,100--294,500
  投资活动现金流出小计1,360,644,472.91,058,822,810.84282,296,959.111,706,136,211.22
  投资活动产生的现金流量净额-715,537,715.3-611,360,310.61-19,953,914.74-554,674,387.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金---416,981,732.68
  取得借款收到的现金983,679,626.73878,414,648.92159,689,298.6486,974,381.3
  收到其他与筹资活动有关的现金34,560,10034,571,0002,200,00024,270,000
  筹资活动现金流入小计1,018,239,726.73912,985,648.92161,889,298.6928,226,113.98
  偿还债务支付的现金432,191,416.68309,620,363.8956,602,165.54704,906,078.12
  分配股利、利润或偿付利息支付的现金133,757,127.54116,761,382.1616,827,553.83110,368,705.93
  支付其他与筹资活动有关的现金107,923,842.39105,481,734.1888,493,722.4626,630,589.93
  筹资活动现金流出小计673,872,386.61531,863,480.23161,923,441.83841,905,373.98
  筹资活动产生的现金流量净额344,367,340.12381,122,168.69-34,143.2386,320,740
四、汇率变动对现金及现金等价物的影响-7,075,884.06-4,394,515.87-2,501,209.53-2,391,921.44
五、现金及现金等价物净增加额-121,849,135.05-172,347,294.06-53,887,799.03109,104,825.24
  加:期初现金及现金等价物余额844,725,390.32844,725,390.32847,078,806.23735,620,565.08
  期末现金及现金等价物余额722,876,255.27672,378,096.26793,191,007.2844,725,390.32
补充资料:
  净利润-82,993,349.34-154,441,271.11
  资产减值准备-16,706,354.23-15,055,905.42
  固定资产和投资性房地产折旧-81,672,316.4-165,039,794.1
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-81,672,316.4-165,039,794.1
  无形资产摊销-9,052,346.22-15,669,917.96
  长期待摊费用摊销-16,564,091.98-21,095,513.48
  处置固定资产、无形资产和其他长期资产的损失----82,376.19
  固定资产报废损失-191,101.71-412,212.94
  公允价值变动损失--468,185.23--904,860.26
  财务费用-77,127,278.51-141,044,793.07
  投资损失--4,123,928.33-16,781,001.75
  递延所得税--5,825,655.42--34,855,149.38
  其中:递延所得税资产减少--6,935,415.92--39,991,180.97
    递延所得税负债增加-1,109,760.5-5,136,031.59
  存货的减少-62,083,633.82-112,133,031.08
  经营性应收项目的减少--209,296,572.2--53,994,851.18
  经营性应付项目的增加--89,562,810.16-14,179,891.37
  其他-12,065,531.91--4,226,065.2
  现金的期末余额-672,378,096.26-844,725,390.32
  减:现金的期初余额-844,725,390.32-735,620,565.08
  现金及现金等价物的净增加额--172,347,294.06-109,104,825.24
公告日期2026-10-292026-08-222026-04-282026-03-26
审计意见(境内)标准无保留意见
TOP↑